Innovating, Digitalizing and Up-Scaling mRNA Vaccine and Therapeutics Production
RNA platform technology has emerged as one of the most promising and strategic technologies for rapid global vaccination, infectious disease control, biotherapeutics development and preparedness for future healthcare challenges. In this webinar, our guest speakers will be discussing how to harness the full power of this disease-agnostic RNA platform, the key considerations needed for consistent, high-quality mRNA synthesis and how you can intensify manufacturing for rapid therapeutic production.
Attend this webinar to:
- Learn about a high-productivity platform process for high-quality RNA vaccine production
- Recognize the major considerations for mRNA synthesis and production up-scaling
- Explore the potential of mRNA for therapeutics
- Discover how to incorporate techno-economic modeling to support vaccine cost reduction and increased productivity
Speakers
Dr. Zoltán Kis
Lecturer, Department of Chemical and Biological Engineering, The University of Sheffield
Dr. Daniel Dixon
Field Applications Scientist, Thermo Fisher Scientific
Katarina Stenklo
Enterprise Commercial Activation & End-to-end Solutions Leader, Project/Program Management, Cytiva
